OCT New England - 2026
Meet us in Boston for the 18th Annual Outsourcing in Clinical Trials New England
Clinical development is becoming more complex, but bringing innovative therapies to patients shouldn't be. Fortrea's experts will be on hand at OCT New England 2026, to discuss strategies for optimizing trial execution, enhancing operational efficiency, and advancing programs across the development lifecycle.
Stop by Booth #4 to connect with our team and learn how we're helping sponsors navigate today's challenges and tomorrow's opportunities.
Speaking Session Information:
Secure your seat at Fortrea's Featured Presentation:
Presenter: Alicia Baker McDowell, DRSc, MS, EMBAVice President, Head of Regulatory Strategy & Product Development Consulting
Date: Oct. 27
Time: 11:45 AM
One Expert or an Entire Team? The Power of Integrated Consulting in Biotech Development
Successful biotech development is rarely about choosing between one expert or a team. It is about having access to the right expertise at the right time, supported by a model that can scale as development needs evolve.
In this session we will explore:
- The advantages and limitations of relying on a single trusted consultant versus a multidisciplinary team supporting development from IND through commercialization.
- How integrated consulting teams can bring together regulatory, clinical, CMC, biostatistics, medical writing, and market access capabilities to address evolving development needs.
- Strategies for managing increasing complexity as programs progress across functions, stakeholders, and global regions.
- How scalable consulting models can reduce execution risk through coordinated planning, quality oversight, business continuity, and access to specialized support.
- The value of coordinated global perspectives across FDA, EMA, PMDA, NMPA, MHRA, and other regulatory agencies while maximizing limited internal resources.
